Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Shweta Kumar

ID: 1b83a032-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Celltrion Announces Phase III Results for Aflibercept Biosimilar

Big Molecule Watch · April 5, 2023

FDA Commissioner Delivers Remarks at FDA-U.S. Patent and Trademark Office Public Workshop

Big Molecule Watch · January 30, 2023

Amgen Releases 2022 Biosimilar Trends Report

Big Molecule Watch · October 14, 2022

Recent and Proposed Legislation Affecting Biosimilars

Big Molecule Watch · October 12, 2022

Biocon and Alvotech Release Statements on FDA Inspections

Big Molecule Watch · September 8, 2022

Previous

12 3

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog